Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Oncology 43

Oncology

pharma-news-updates-for-roche-mayo-clinic-owlstone-transmedics-google

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Roche inks $3B deal; Owlstone raises $58M; FDA approves OCS heart system; Google, Mayo Clinic build brain-mapping AI algorithm

Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 Billion A collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will collaborate with Adaptimmune for developing and commercializing allogeneic T-cell therapies to treat multiple cancer indications. Under their deal Genentech will work with Adaptimmune to develop “off-the-shelf” allogeneic T-cell therapies for up to five shared cancer targets, and a novel allogeneic personalized cell therapy platform from which personalized allogeneic T-cell therapies would be developed. Adaptimmune CEO Adrian Rawcliffe said in a statement that throu...

Explore More...

Notizia

Idera’s Phase I Data; DelMar Initiates Trial; Novartis’ study; Humira gets EC approval

HDAC

HDAC (Histone Deacetylase) Inhibitors – A Promising Anti-Cancer Target

Entasis

CAR-T Phase I trials; ContraVir Announces; Merck acquired; Excision BioTherapeutics bags $10M

Cancer Globally (Vol. 1, Issue 1)

Bruton’s Tyrosine Kinase (BTK) Inhibitors An Emerging Therapeutic Target

Can-Fite Receives Payment; Leafbuyer Technologies and Denver Post’s Cannabist; EPX-300 & JOTROL received Designation; New treatment Approved for adults

PARP Inhibitors making inroads into Ovarian Cancer

Business CockTail

Default Blog Image

CDK 4/6 Inhibitors- The Changing Paradigm for Breast Cancer Treatment

Personalized Medicine

Allergan sell; AZ, Merck team up; Roche’s MS drug; Chinese API maker receives a warning letter

Takeda scores; PhRMA launches; Valeant’s Obagi; Ex-Novo executive signs

Gilead faces lawsuit; Herceptin stalled; Lilly revs up, Abemaciclib gets nod; Key Humira patent gets struck down

Actinic keratosis

Actinic Keratosis – A Warning Sign for Potential Skin Cancer

Takeda knocks Velcade; FDA nod awaited; Novartis gets approval; Astellas UK dodges; Haegarda set for launch

Novartis on AMD drug; Hospira recall of vials; Takeda wraps up; FDA bans imports

J&J nabs; Clovis plots Rubraca; Novartis scores EU approval; Seattle Genetics stops trials

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly